103 Aortic inflammation is reduced, and paralelles changes in aortic stiffness by anti-TNF α therapy in rheumatoid arthritis
Identifieur interne : 000225 ( Main/Exploration ); précédent : 000224; suivant : 000226103 Aortic inflammation is reduced, and paralelles changes in aortic stiffness by anti-TNF α therapy in rheumatoid arthritis
Auteurs : K M Maki-Petaja [Royaume-Uni] ; M. Elkhawad [Royaume-Uni] ; F. Joshi [Royaume-Uni] ; F. Hall [Royaume-Uni] ; A. Ostor [Royaume-Uni] ; J. Cheriyan [Royaume-Uni] ; J H Rudd [Royaume-Uni] ; I B Wilkinson [Royaume-Uni]Source :
- Heart [ 1355-6037 ] ; 2012-05.
Abstract
Background Rheumatoid arthritis (RA) is a systemic inflammatory condition associated with increased cardiovascular risk which is not fully explained by traditional risk factors. Endothelial dysfunction and increased aortic stiffness may mediate some of the increased risk. Additionally, there may be direct vascular inflammation which could directly accelerate atherosclerosis. We hypothesised that patients with RA exhibit a subclinical aortic vasculitis which can be reversed with anti-tumour necrosis factor α (TNF) therapy. Methods The aortas and carotid arteries of 15 patients with severe rheumatoid arthritis were imaged before and after anti-TNF therapy using 18F-fluoro-deoxyglucose positron emission tomography (FDG-PET) with CT co-registration. Tracer uptake was analysed in various arterial segments by measuring maximum standard uptake values (SUV) and subsequently corrected for blood uptake to obtain a target to background ratio (TBR). Carotid to femoral pulse wave velocity (PWV) as a measure of aortic stiffness, disease activity and inflammatory biomarkers were also measured. Results Mean baseline aortic TBR was 2.07±0.20. Following anti-TNF α therapy, there was a significant reduction in abdominal aortic TBR (−0.18±0.27, p=0.03) and in the most diseased segment in the whole aorta (−0.48±0.59, p=0.01). TBR was also reduced in all other aortic segments and the proportion of hot slices (defined as TBR>1.9) was reduced by 31%, but these did not reach statistical significance. There was no change in carotid TBR following treatment. Aortic PVW was reduced by 0.43±1.0 m/s, p=0.1) and there was a significant correlation between a reduction in aortic PWV and abdominal TBR (R=0.57, p=0.03) and between aortic PWV and proportion of “hot” slices (R=0.66, p=0.01). There was a concomitant reduction in serum CRP (−8±12 mg/l, p=0.02) and disease activity (DAS28 −1.41±1.51, p=0.002). Conclusions This study demonstrates for the first time that patients with RA have high aortic and carotid FDG uptake, suggesting subclinical vasculitis. Moreover, they exhibit a reduction in FDG uptake following anti-TNFα therapy, which correlated with a reduction in aortic stiffness. These results suggest that subclinical vasculitis could be the mechanism behind the increased cardiovascular risk and that effective treatment of inflammation may help to reduce the cardiovascular risk in this patient population.
Url:
DOI: 10.1136/heartjnl-2012-301877b.103
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C75
- to stream Istex, to step Curation: 000C75
- to stream Istex, to step Checkpoint: 000027
- to stream Main, to step Merge: 000228
- to stream Main, to step Curation: 000225
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>103 Aortic inflammation is reduced, and paralelles changes in aortic stiffness by anti-TNF α therapy in rheumatoid arthritis</title>
<author><name sortKey="Maki Petaja, K M" sort="Maki Petaja, K M" uniqKey="Maki Petaja K" first="K M" last="Maki-Petaja">K M Maki-Petaja</name>
</author>
<author><name sortKey="Elkhawad, M" sort="Elkhawad, M" uniqKey="Elkhawad M" first="M" last="Elkhawad">M. Elkhawad</name>
</author>
<author><name sortKey="Joshi, F" sort="Joshi, F" uniqKey="Joshi F" first="F" last="Joshi">F. Joshi</name>
</author>
<author><name sortKey="Hall, F" sort="Hall, F" uniqKey="Hall F" first="F" last="Hall">F. Hall</name>
</author>
<author><name sortKey="Ostor, A" sort="Ostor, A" uniqKey="Ostor A" first="A" last="Ostor">A. Ostor</name>
</author>
<author><name sortKey="Cheriyan, J" sort="Cheriyan, J" uniqKey="Cheriyan J" first="J" last="Cheriyan">J. Cheriyan</name>
</author>
<author><name sortKey="Rudd, J H" sort="Rudd, J H" uniqKey="Rudd J" first="J H" last="Rudd">J H Rudd</name>
</author>
<author><name sortKey="Wilkinson, I B" sort="Wilkinson, I B" uniqKey="Wilkinson I" first="I B" last="Wilkinson">I B Wilkinson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:653516C2169B8D47DCF581C40B52EB7DC6F40469</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1136/heartjnl-2012-301877b.103</idno>
<idno type="url">https://api.istex.fr/document/653516C2169B8D47DCF581C40B52EB7DC6F40469/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C75</idno>
<idno type="wicri:Area/Istex/Curation">000C75</idno>
<idno type="wicri:Area/Istex/Checkpoint">000027</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000027</idno>
<idno type="wicri:doubleKey">1355-6037:2012:Maki Petaja K:aortic:inflammation:is</idno>
<idno type="wicri:Area/Main/Merge">000228</idno>
<idno type="wicri:Area/Main/Curation">000225</idno>
<idno type="wicri:Area/Main/Exploration">000225</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">103 Aortic inflammation is reduced, and paralelles changes in aortic stiffness by anti-TNF α therapy in rheumatoid arthritis</title>
<author><name sortKey="Maki Petaja, K M" sort="Maki Petaja, K M" uniqKey="Maki Petaja K" first="K M" last="Maki-Petaja">K M Maki-Petaja</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elkhawad, M" sort="Elkhawad, M" uniqKey="Elkhawad M" first="M" last="Elkhawad">M. Elkhawad</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joshi, F" sort="Joshi, F" uniqKey="Joshi F" first="F" last="Joshi">F. Joshi</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hall, F" sort="Hall, F" uniqKey="Hall F" first="F" last="Hall">F. Hall</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ostor, A" sort="Ostor, A" uniqKey="Ostor A" first="A" last="Ostor">A. Ostor</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cheriyan, J" sort="Cheriyan, J" uniqKey="Cheriyan J" first="J" last="Cheriyan">J. Cheriyan</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rudd, J H" sort="Rudd, J H" uniqKey="Rudd J" first="J H" last="Rudd">J H Rudd</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wilkinson, I B" sort="Wilkinson, I B" uniqKey="Wilkinson I" first="I B" last="Wilkinson">I B Wilkinson</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Heart</title>
<title level="j" type="abbrev">Heart</title>
<idno type="ISSN">1355-6037</idno>
<idno type="eISSN">1468-201X</idno>
<imprint><publisher>BMJ Publishing Group Ltd and British Cardiovascular Society</publisher>
<date type="published" when="2012-05">2012-05</date>
<biblScope unit="volume">98</biblScope>
<biblScope unit="issue">Suppl 1</biblScope>
<biblScope unit="page" from="A59">A59</biblScope>
</imprint>
<idno type="ISSN">1355-6037</idno>
</series>
<idno type="istex">653516C2169B8D47DCF581C40B52EB7DC6F40469</idno>
<idno type="DOI">10.1136/heartjnl-2012-301877b.103</idno>
<idno type="href">heartjnl-98-A59-2.pdf</idno>
<idno type="ArticleID">heartjnl-2012-301877b.103</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1355-6037</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">Background Rheumatoid arthritis (RA) is a systemic inflammatory condition associated with increased cardiovascular risk which is not fully explained by traditional risk factors. Endothelial dysfunction and increased aortic stiffness may mediate some of the increased risk. Additionally, there may be direct vascular inflammation which could directly accelerate atherosclerosis. We hypothesised that patients with RA exhibit a subclinical aortic vasculitis which can be reversed with anti-tumour necrosis factor α (TNF) therapy. Methods The aortas and carotid arteries of 15 patients with severe rheumatoid arthritis were imaged before and after anti-TNF therapy using 18F-fluoro-deoxyglucose positron emission tomography (FDG-PET) with CT co-registration. Tracer uptake was analysed in various arterial segments by measuring maximum standard uptake values (SUV) and subsequently corrected for blood uptake to obtain a target to background ratio (TBR). Carotid to femoral pulse wave velocity (PWV) as a measure of aortic stiffness, disease activity and inflammatory biomarkers were also measured. Results Mean baseline aortic TBR was 2.07±0.20. Following anti-TNF α therapy, there was a significant reduction in abdominal aortic TBR (−0.18±0.27, p=0.03) and in the most diseased segment in the whole aorta (−0.48±0.59, p=0.01). TBR was also reduced in all other aortic segments and the proportion of hot slices (defined as TBR>1.9) was reduced by 31%, but these did not reach statistical significance. There was no change in carotid TBR following treatment. Aortic PVW was reduced by 0.43±1.0 m/s, p=0.1) and there was a significant correlation between a reduction in aortic PWV and abdominal TBR (R=0.57, p=0.03) and between aortic PWV and proportion of “hot” slices (R=0.66, p=0.01). There was a concomitant reduction in serum CRP (−8±12 mg/l, p=0.02) and disease activity (DAS28 −1.41±1.51, p=0.002). Conclusions This study demonstrates for the first time that patients with RA have high aortic and carotid FDG uptake, suggesting subclinical vasculitis. Moreover, they exhibit a reduction in FDG uptake following anti-TNFα therapy, which correlated with a reduction in aortic stiffness. These results suggest that subclinical vasculitis could be the mechanism behind the increased cardiovascular risk and that effective treatment of inflammation may help to reduce the cardiovascular risk in this patient population.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Angleterre de l'Est</li>
</region>
<settlement><li>Cambridge</li>
</settlement>
<orgName><li>Université de Cambridge</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Maki Petaja, K M" sort="Maki Petaja, K M" uniqKey="Maki Petaja K" first="K M" last="Maki-Petaja">K M Maki-Petaja</name>
</region>
<name sortKey="Cheriyan, J" sort="Cheriyan, J" uniqKey="Cheriyan J" first="J" last="Cheriyan">J. Cheriyan</name>
<name sortKey="Elkhawad, M" sort="Elkhawad, M" uniqKey="Elkhawad M" first="M" last="Elkhawad">M. Elkhawad</name>
<name sortKey="Hall, F" sort="Hall, F" uniqKey="Hall F" first="F" last="Hall">F. Hall</name>
<name sortKey="Joshi, F" sort="Joshi, F" uniqKey="Joshi F" first="F" last="Joshi">F. Joshi</name>
<name sortKey="Ostor, A" sort="Ostor, A" uniqKey="Ostor A" first="A" last="Ostor">A. Ostor</name>
<name sortKey="Rudd, J H" sort="Rudd, J H" uniqKey="Rudd J" first="J H" last="Rudd">J H Rudd</name>
<name sortKey="Wilkinson, I B" sort="Wilkinson, I B" uniqKey="Wilkinson I" first="I B" last="Wilkinson">I B Wilkinson</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Eau/explor/LotaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000225 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000225 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Eau |area= LotaV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:653516C2169B8D47DCF581C40B52EB7DC6F40469 |texte= 103 Aortic inflammation is reduced, and paralelles changes in aortic stiffness by anti-TNF α therapy in rheumatoid arthritis }}
This area was generated with Dilib version V0.6.39. |